查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1923031

泌尿系統耗材市場按產品類型、材料、最終用戶、應用和分銷管道分類－2026年至2032年全球預測

Urology Disposable Market by Product Type, Material, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年泌尿系統一次性用品市場價值將達到 51.8 億美元，到 2026 年將成長至 55.4 億美元，到 2032 年將達到 87.5 億美元，年複合成長率為 7.76%。

關鍵市場統計數據
基準年 2025 51.8億美元
預計年份：2026年 55.4億美元
預測年份 2032 87.5億美元
複合年成長率 (%) 7.76%

一個全面的泌尿系統拋棄式產品框架，重點在於闡述感染疾病控制優先事項、技術趨勢以及影響相關人員決策的關鍵採購問題。

泌尿系統拋棄式產品生態系處於臨床安全、手術創新及營運效率需求三者交會點。臨床醫生越來越傾向於使用一次性解決方案，以降低交叉感染風險並簡化再處理流程；同時，供應鏈領導者也在仔細權衡每次手術的成本與可預測庫存管理的效益。此外，製造商也在增加對材料科學、人體工學設計和整合診斷功能的投入，以滿足臨床和採購的雙重需求。

對泌尿系統拋棄式產品重大變革進行策略性回顧，這些變革由一次性產品的普及、材料創新、監管力度加大以及商業模式的演變所驅動。

過去幾年，泌尿系統一次性醫療設備的研發、採購和使用方式發生了翻天覆地的變化。其中一個關鍵促進因素是臨床上對一次性內視鏡和微創一次性醫療設備的需求日益成長，這些器械能夠最大限度地減少交叉感染，並縮短手術間的周轉時間。同時，光學技術、感測器小型化和一次性器材整合方面的技術進步，正在拓展以往可重複使用技術的臨床效用，催生新的採購類別，並改變醫療服務提供者的價值提案。

分析2025年關稅累積變化如何影響泌尿系統拋棄式產品價值鏈中的採購決策、供應商策略和製造地。

2025年關稅調整所塑造的政策環境對泌尿系統一次性醫療設備供應鏈的採購經濟、供應商策略和製造地地點產生了累積影響。進口關稅和商品分類的變化促使許多買家重新評估其到岸成本並考慮其他採購方案。為此，一些大型採購商加快了供應商多元化進程，而另一些採購商則提高了本地庫存水平，以應對價格波動和前置作業時間的變化。

綜合分析市場細分，整合產品分類、終端使用者行為、材料選擇、通路和臨床應用細節，進而驅動策略決策。

細分市場分析揭示了產品系列、醫療環境、材料、通路和臨床應用等方面的顯著趨勢，這些趨勢均可指南製造商和採購商的策略優先排序。產品層面的洞察表明，包括Foley導管導管、間歇性導尿管和腎造瘻管在內的導管類別仍然是採購計劃的基礎，而一次性內視鏡和手術專用配件的成長正在影響相關策略和售後服務。一次性內視鏡和導管導引線在臨床上的重要性日益凸顯，有助於提高診斷和治療流程的效率。

從細緻入微的區域觀點比較美洲、歐洲、中東和非洲以及亞太地區等區域叢集的採用促進因素、監管壓力和供應鏈優先事項。

區域趨勢將對美洲、歐洲、中東和非洲以及亞太市場的創新軌跡、監管時間表和採購模式產生重大影響。在美洲，大型醫院系統採購部門的整合以及對感染控制的重視，推動了一次性醫療技術的應用，而報銷機制和採購週期則繼續影響技術的普及速度。因此，專注於該地區的供應商通常會優先考慮臨床證據的產生以及與綜合醫療網路的夥伴關係。

主要企業層面洞察，著重闡述了透過技術領先、製造韌性、策略聯盟和以客戶為中心的服務模式實現競爭差異化的關鍵要素。

泌尿系統拋棄式領域，主要企業企業與新興企業之間的競爭以技術差異化、智慧財產權保護以及與醫療系統和分銷管道的策略聯盟為特徵。創新重點在於一次性影像設備和單次使用診斷平台，以及人體工學改進和材料重新設計，以最佳化臨床可用性和安全性。研發投入與實際應用效果和下游成本影響相符的企業，更有可能獲得大型採購商的優先供應商地位。

為產業領導者提供切實可行的策略建議，以整合臨床證據、生產韌性、環境管理和創新商業模式，以實現永續成長。

產業領導者可以採取一系列重點突出、切實可行的策略，在確保臨床應用的同時，增強商業性韌性。首先，他們應優先產生臨床證據，將產品屬性與特定的手術效率和病人安全結果連結。這將有助於製造商簡化採購談判，並加速產品被納入藥品目錄。其次，為了降低關稅風險和物流波動，他們可以實現製造地多元化，並投資鄰近地區的產能，從而提高客戶前置作業時間的可預測性。

我們採用透明的調查方法，結合一手訪談、二手合規性調查、交叉檢驗和專家同行評審，以提供可操作且檢驗的行業洞察。

本研究整合了訪談、文獻回顧和系統檢驗步驟，以確保研究結果的可靠性和可重複性。訪談對象包括採購主管、臨床主導者、製造商和經銷合作夥伴，旨在了解實際決策架構、應用障礙和供應鏈行為。此外，本研究也對監管指南、技術白皮書和醫療設備標籤進行了嚴格的審查，以確保研究結果符合最新的合規和安全標準。

對臨床需求、材料和監管趨勢以及供應鏈韌性如何共同決定泌尿系統拋棄式領域的策略贏家進行權威、全面的分析。

總之，泌尿系統拋棄式產業正處於一個策略轉折點，臨床需求、材料創新、監管變革和供應鏈韌性在此交匯融合。一次性技術和升級版拋棄式平台正在重塑手術流程和採購重點，而關稅調整和區域政策變化則凸顯了生產柔軟性和供應商多元化的必要性。這些因素共同作用，正在重塑那些能夠展現臨床價值、營運可靠性和環境責任的企業的競爭優勢。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章泌尿系統耗材市場（依產品類型分類）

  • 導管
    • Foley導管
    • 間歇性
    • 腎造瘻術
  • 擴充器
  • 免洗內視鏡
  • 引流袋
  • 導管導引線
  • 輸尿管支架

第9章泌尿系統耗材市場（依材料分類）

  • 乳膠
  • PVC
  • 矽酮
  • 熱可塑性橡膠

第10章泌尿系統耗材市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院

第11章泌尿系統耗材市場（依應用領域分類）

  • 診斷
  • 監測
  • 治療
    • 切片檢查
    • 移除石頭
    • 狹窄擴張

第12章泌尿系統耗材市場（依通路分類）

  • 離線
  • 線上

第13章泌尿系統耗材市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章泌尿系統耗材市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國泌尿系統耗材市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國泌尿系統一次性用品市場

第17章：中國泌尿系統一次性用品市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accurate Surgicare
  • Ace Medical Devices Pvt. Ltd.
  • Advin Health Care
  • Angiplast Pvt. Ltd.
  • Apex Medical Devices
  • Ask Enterprise
  • Aster Medispro Pvt. Ltd.
  • Bellcross Industries Pvt. Ltd.
  • Bhagwati Medicare Devices
  • BHN Surgicals Private Limited
  • Cliniva Healthcare
  • D4 Surgicals India Pvt. Ltd.
  • Dhwanit Enterprise
  • EDAP TMS SA
  • Essentia Business Private Limited
  • Euromedix Healthcare
  • Focuz Medical Technologies LLP
  • George Philips Medical Engineering Private Limited
  • Global Medi Innovations
  • Glowtronics Pvt. Ltd.
  • Jay Shakti Industries
  • Kanav Healthcare Pvt. Ltd.
Product Code: MRR-867BED9A9ED7

The Urology Disposable Market was valued at USD 5.18 billion in 2025 and is projected to grow to USD 5.54 billion in 2026, with a CAGR of 7.76%, reaching USD 8.75 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.18 billion
Estimated Year [2026] USD 5.54 billion
Forecast Year [2032] USD 8.75 billion
CAGR (%) 7.76%

A panoramic framing of the urology disposable landscape that highlights infection control priorities, technology trajectories, and procurement imperatives shaping stakeholder decisions

The urology disposable ecosystem sits at the intersection of clinical safety imperatives, procedural innovation, and operational efficiency demands. Clinicians increasingly prioritize single-use solutions to reduce cross-contamination risk and simplify reprocessing logistics, while supply chain leaders weigh the trade-offs between per-procedure costs and the benefits of predictable inventory management. At the same time, manufacturers are channeling investment into material science, ergonomic design, and integrated diagnostic capabilities to meet both clinical and procurement requirements.

Consequently, stakeholders must navigate a multifaceted landscape where regulatory scrutiny, environmental considerations, and reimbursement pressures converge. Hospitals and ambulatory surgical centers seek devices that deliver clinical equivalence or superiority while lowering total procedural burden. Meanwhile, product developers are accelerating efforts to demonstrate clear comparative advantages through clinical evidence and lifecycle assessments. This introduction frames the broader narrative: an industry propelled by infection control, evolving clinical pathways, and the imperative to align product innovation with pragmatic delivery models.

A strategic review of the major transformative shifts in urology disposables driven by single-use adoption, material innovation, regulatory tightening, and evolving commercial models

Over the past several years, transformative shifts have reshaped how urology disposables are developed, procured, and used. A primary driver has been the accelerated clinical preference for single-use endoscopes and minimally invasive disposables that minimize cross-contamination and reduce turnaround times between cases. In parallel, technological advances in optics, sensor miniaturization, and disposable integration have expanded the clinical utility of once reusable-only technologies, creating new procurement categories and altering value propositions for providers.

Furthermore, sustainability conversations are no longer peripheral; manufacturers and health systems are adopting more rigorous lifecycle assessments and exploring recyclable or lower-impact materials. This transition interacts with regulatory trends that demand clearer labeling, traceability, and post-market surveillance, thereby influencing design choices and supplier selection. Consequently, commercial models are evolving from simple product sales toward bundled procurement contracts, service-level guarantees, and outcome-linked agreements. These consequential shifts are redefining competitive dynamics and creating opportunities for entrants that pair clinical differentiation with supply chain resilience and environmental responsibility.

An analytical account of how cumulative tariff changes in 2025 reshaped sourcing decisions, supplier strategies, and manufacturing footprints across the urology disposables value chain

The policy environment shaped by tariff adjustments in 2025 has exerted a cumulative effect on procurement economics, supplier strategy, and manufacturing footprints across the urology disposable supply chain. Import duties and classification changes prompted many buyers to reassess landed costs and consider alternative sourcing options. In response, some large purchasers accelerated supplier diversification, while others increased local stocking levels to buffer against pricing volatility and customs lead-time variability.

Moreover, manufacturers facing elevated input and logistics costs explored multi-pronged mitigation strategies. These included reallocating production to lower-tariff jurisdictions, absorbing some cost increments to preserve market share, and entering strategic pricing agreements with health systems. Such moves had downstream implications: hospitals and ambulatory surgical centers adjusted purchasing cycles, deferred non-essential product line conversions, and intensified negotiations around rebate structures and bundled purchasing commitments.

Consequently, the tariff-driven adjustments stimulated a broader reassessment of supply chain resilience. Procurement teams placed higher value on near-shore manufacturing partnerships and on suppliers with transparent cost pass-through mechanisms. Over time, these dynamics encouraged investments in domestic capacity and supplier qualification programs to reduce exposure to geopolitical trade shifts, thereby altering the competitive calculus for both global and regional suppliers.

Comprehensive segmentation insights integrating product taxonomy, end-user behavior, material choices, distribution pathways, and clinical application nuances that drive strategic decisions

Segmentation analysis reveals differentiated dynamics across product families, care settings, materials, channels, and clinical applications, each of which informs strategic prioritization for manufacturers and buyers. Product-level insights indicate that the catheter category, encompassing Foley, intermittent, and nephrostomy variants, remains foundational to procurement programs, while growth in single-use disposable endoscopes and procedure-specific accessories influences adjacency strategies and aftermarket services. Disposable endoscopes and guidewires are drawing increased clinical attention as they enable more streamlined diagnostic and therapeutic workflows.

End user segmentation shows distinct purchasing behaviors across ambulatory surgical centers, clinics, and hospitals, with ASCs favoring high-throughput, single-use items that shorten turnover times and clinics emphasizing cost containment and ease of use. Material choices-latex, PVC, silicone, and thermoplastic elastomer-create trade-offs between biocompatibility, flexibility, and environmental footprint, and these material considerations are increasingly factored into procurement approvals. Distribution channel dynamics reflect the coexistence of direct sales, distributors, and online channels, each offering different service levels, pricing structures, and inventory models.

Finally, application-based segmentation spanning diagnosis, monitoring, and treatment, including biopsy, stone removal, and stricture dilation, highlights where clinical demand concentrates and where product innovation can unlock higher clinical utility. By integrating these segmentation lenses, decision makers can better align product development, regulatory strategy, and commercial go-to-market plans to the nuanced needs of each end-user cohort and clinical use case.

A nuanced regional perspective that contrasts adoption drivers, regulatory pressures, and supply chain priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific clusters

Regional dynamics exercise a significant influence on innovation trajectories, regulatory timelines, and procurement models across the Americas, Europe, Middle East & Africa, and Asia-Pacific markets. In the Americas, buyer consolidation among large hospital systems and an emphasis on infection control have supported adoption of single-use technologies, while reimbursement mechanisms and procurement cycles continue to shape pace of uptake. Consequently, suppliers focusing on this region often prioritize clinical evidence generation and partnerships with integrated delivery networks.

In Europe, Middle East & Africa, regulatory harmonization efforts and diverse reimbursement landscapes demand regionally tailored product registries and compliance strategies. Moreover, environmental policies in parts of Europe have accelerated attention on product lifecycle impacts, prompting manufacturers to present comprehensive sustainability assessments. Across Asia-Pacific, rapid procedural volume growth, expanding ambulatory care capacity, and cost-sensitivity create a fertile environment for innovative price-performance propositions; as a result, local manufacturing partnerships and scalable distribution models are especially valuable.

Trans-regional considerations include logistical complexity, regulatory divergence, and shifting tariff regimes, all of which influence where companies invest in local production, warehouse footprints, and customer support. Understanding these regional distinctions allows stakeholders to calibrate supply chain investments, clinical engagement programs, and market entry tactics for each geographic cluster.

Key company-level insights highlighting competitive differentiation through technology leadership, manufacturing resilience, strategic alliances, and customer-centric service models

Competitive dynamics among leading and emerging firms in the urology disposable sector are characterized by technology differentiation, intellectual property focus, and strategic partnerships with health systems and distribution channels. Innovation pipelines emphasize disposable imaging and single-use diagnostic platforms, coupled with ergonomic enhancements and material reformulations to optimize clinical handling and safety. Companies that align R&D investments with real-world clinical outcomes and downstream cost implications tend to secure preferred supplier status with large purchasers.

Operational excellence is another differentiator: manufacturers with validated quality systems, scalable production processes, and integrated supply chain visibility offer lower procurement risk and tend to win multi-year contracts. Additionally, strategic collaborations and selective acquisitions have allowed some players to expand complementary portfolios, enhance manufacturing footprints, and accelerate regulatory clearances in target geographies. Financially disciplined firms have focused on manufacturing automation, vertical integration of critical components, and redundant supplier networks to reduce exposure to external shocks.

Finally, customer engagement models are evolving beyond transactional sales. Vendors that provide training, clinical evidence packages, and logistics support, while demonstrating commitment to lifecycle stewardship, are better positioned to capture long-term relationships with hospitals, ambulatory centers, and large clinics. These competitive behaviors underscore the importance of aligning product innovation with demonstrable operational and clinical benefits.

Actionable strategic recommendations for industry leaders to align clinical evidence, manufacturing resilience, environmental stewardship, and innovative commercial models for sustainable growth

Industry leaders can pursue a set of focused, actionable strategies to secure clinical adoption while strengthening commercial resilience. First, prioritize clinical evidence generation that ties product features to tangible procedural efficiencies and patient safety outcomes; by doing so, manufacturers can simplify procurement discussions and accelerate formulary inclusion. Second, invest in diversified manufacturing footprints and near-shore capacity to mitigate tariff exposure and logistics volatility, thereby improving lead-time predictability for customers.

Third, incorporate lifecycle and environmental impact assessments into product narratives to respond to increasing sustainability requirements from regulators and buyers. Fourth, refine commercial models to include outcome-based agreements, bundled procurement options, and tailored support services for ambulatory surgical centers and clinics that have different usage profiles than large hospitals. Fifth, strengthen partnerships with distributors and digital platforms to expand reach while maintaining consistent quality and service standards.

By acting on these priorities, companies can reduce transactional friction, create stickier customer relationships, and position themselves to capture demand shifts that favor innovation, transparency, and operational reliability. These recommendations provide a pragmatic blueprint for aligning R&D, manufacturing, and commercial execution with evolving market expectations.

A transparent research methodology integrating primary interviews, secondary compliance review, cross-validation checks, and expert peer review to produce actionable, verifiable industry insights

This research synthesizes primary interviews, secondary literature review, and structured validation steps to ensure robust, reproducible insights. Primary research involved targeted interviews with procurement leaders, clinical champions, manufacturers, and distribution partners to capture real-world decision frameworks, adoption barriers, and supply chain behaviors. These qualitative inputs were complemented by a rigorous review of regulatory guidance, technical whitepapers, and device labeling to ensure alignment with the latest compliance and safety standards.

Data synthesis included cross-validation of interview findings against documented product approvals, patent filings, and supplier announcements, with a focus on triangulating claims related to innovation, manufacturing investments, and distribution strategies. The segmentation approach combined product, end-user, material, channel, and application lenses to reflect the multidimensional nature of procurement and clinical decision making. Finally, analytical outputs underwent peer review among subject matter experts to refine interpretations and to ensure that recommendations were actionable and relevant to both commercial and clinical audiences.

Through this methodology, the report delivers a balanced perspective grounded in practitioner insights and verifiable documentation, supporting stakeholders seeking to translate strategic intelligence into operational initiatives.

A conclusive synthesis of how clinical demand, material and regulatory trends, and supply chain resilience collectively determine strategic winners in the urology disposables arena

In conclusion, the urology disposable sector is at a strategic inflection point where clinical imperatives, material innovation, regulatory evolution, and supply chain resilience converge. Single-use technologies and enhanced disposable platforms are redefining procedural workflows and procurement priorities, while tariff adjustments and regional policy shifts have underscored the need for manufacturing flexibility and supplier diversification. These combined forces are reshaping competitive advantage toward firms that can demonstrate clinical value, operational reliability, and environmental responsibility.

Looking ahead, stakeholders that proactively invest in evidence generation, near-shore capabilities, and sustainable materials will be better positioned to meet evolving buyer expectations. Moreover, aligning commercial models with the nuanced needs of hospitals, ambulatory surgical centers, and clinics will accelerate adoption and create recurring revenue pathways. Ultimately, success will favor organizations that translate technical innovation into clear clinical and operational outcomes, while maintaining a resilient and adaptable supply model that anticipates regulatory and geopolitical shifts.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Disposable Market, by Product Type

  • 8.1. Catheters
    • 8.1.1. Foley
    • 8.1.2. Intermittent
    • 8.1.3. Nephrostomy
  • 8.2. Dilators
  • 8.3. Disposable Endoscopes
  • 8.4. Drainage Bags
  • 8.5. Guidewires
  • 8.6. Ureteral Stents

9. Urology Disposable Market, by Material

  • 9.1. Latex
  • 9.2. PVC
  • 9.3. Silicone
  • 9.4. Thermoplastic Elastomer

10. Urology Disposable Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Urology Disposable Market, by Application

  • 11.1. Diagnosis
  • 11.2. Monitoring
  • 11.3. Treatment
    • 11.3.1. Biopsy
    • 11.3.2. Stone Removal
    • 11.3.3. Stricture Dilation

12. Urology Disposable Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Urology Disposable Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Urology Disposable Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Urology Disposable Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Urology Disposable Market

17. China Urology Disposable Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accurate Surgicare
  • 18.6. Ace Medical Devices Pvt. Ltd.
  • 18.7. Advin Health Care
  • 18.8. Angiplast Pvt. Ltd.
  • 18.9. Apex Medical Devices
  • 18.10. Ask Enterprise
  • 18.11. Aster Medispro Pvt. Ltd.
  • 18.12. Bellcross Industries Pvt. Ltd.
  • 18.13. Bhagwati Medicare Devices
  • 18.14. BHN Surgicals Private Limited
  • 18.15. Cliniva Healthcare
  • 18.16. D4 Surgicals India Pvt. Ltd.
  • 18.17. Dhwanit Enterprise
  • 18.18. EDAP TMS S.A.
  • 18.19. Essentia Business Private Limited
  • 18.20. Euromedix Healthcare
  • 18.21. Focuz Medical Technologies LLP
  • 18.22. George Philips Medical Engineering Private Limited
  • 18.23. Global Medi Innovations
  • 18.24. Glowtronics Pvt. Ltd.
  • 18.25. Jay Shakti Industries
  • 18.26. Kanav Healthcare Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY DISPOSABLE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL UROLOGY DISPOSABLE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA UROLOGY DISPOSABLE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY FOLEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY FOLEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY FOLEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY NEPHROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY NEPHROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY NEPHROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DISPOSABLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DISPOSABLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DISPOSABLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DRAINAGE BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DRAINAGE BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DRAINAGE BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY LATEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY LATEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY LATEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY STONE REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY STONE REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY STONE REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS UROLOGY DISPOSABLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GCC UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 158. GCC UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. GCC UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. GCC UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. GCC UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 162. GCC UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. G7 UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. G7 UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. G7 UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. G7 UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 186. G7 UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. NATO UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. NATO UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. NATO UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. NATO UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 194. NATO UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL UROLOGY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA UROLOGY DISPOSABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA UROLOGY DISPOSABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA UROLOGY DISPOSABLE MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA UROLOGY DISPOSABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA UROLOGY DISPOSABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA UROLOGY DISPOSABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA UROLOGY DISPOSABLE MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA UROLOGY DISPOSABLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)